Ivor Elrifi insider trades: Tiziana Life Sciences (TLSA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ivor reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | TLSA | ↑ Buy | 321,423 | $0.99 | $319K | By trust | Aug 6, 2026 (1d) |
| Aug 3, 2026 | TLSA | ↑ Buy | 667,000 | $1.00 | $667K | By trust | Aug 5, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLSA insiders
Open-market trades in the last 12 months
About Ivor Elrifi's insider trades
Ivor Elrifi is Chief Executive Officer at Tiziana Life Sciences (TLSA). Since Aug 3, 2026, Ivor has reported 2 open-market purchases worth $986K and no sales on SEC Form 4. In the last 12 months: 2 buys ($986K).
Their filings also include option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.